Form 4 for REGN Regeneron Pharmaceuticals

Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-18 · accession 0001708138-21-000064 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2021-08-20	2021-08-19	REGN	SCHLEIFER LEONARD S	Pres, CEO, Dir	S - Sale	$660.03	-10.0K	21.2K	-32%	-$6.60M
	2021-08-20	2021-08-18	REGN	SCHLEIFER LEONARD S	Pres, CEO, Dir	S - Sale	$650.03	-200.0K	304.7K	-40%	-$130.01M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-08-19	S	D	10,000	$660.03	21,178	I	—	—	(F3) Represents volume-weighted average price of sales of 10,000 shares of Company stock on August 19, 2021 at prices ranging from $660.00 to $660.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 19, 2021 at each separate price.
2	Common	Common Stock	2021-08-18	S	D	200,000	$650.03	304,746	D By Trust	—	—	(F2) Represents volume-weighted average price of sales of 200,000 shares of Company stock on August 18, 2021 at prices ranging from $650.00 to $650.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 18, 2021 at each separate price. (F4) These shares are held in a trust for the benefit of the reporting person's family members. The reporting person's spouse is a trustee of the trust.